Newsroom
-
March 2 , 2020
The rise of the CRO
- Dr Chris Doherty discusses the rise of clinical research organisations (CROs) from his vantage point as managing director at Alderley Park.
Read more -
March 1 , 2020
The top 10 drugs losing U.S. exclusivity in 2020
- Each year, drugmakers face costly losses of exclusivity for big-selling old medicines, forcing them to continually develop and launch new drugs as they strive for growth. While some major brands like Lyrica and Herceptin lost exclusivity last year—with more expected for the coming years—2020 will feature the introduction of important new generics, as well.
Read more -
March 1 , 2020
Chinese biotech bags $50M+ for I/O, autoimmune work, starting with ALK5 inhibitor
- For the last decade or so, many of the more eye-catching Chinese biotech startups share two defining attributes: seasoned execs trained at multinational biopharma companies and a mission to bridge the gap between Western medical breakthroughs and Chinese patients.
Read more -
February 25 , 2020
Biotech company Moderna says its coronavirus vaccine is ready for first tests
- US biotech firm Moderna has shipped an experimental coronavirus vaccine to US government researchers just six weeks after it started working on the immunization.
Read more -
February 18 , 2020
The top 100 biopharma venture investors at the megabillions deal table
- The VC crowd took a step back last year, but nevertheless maintained a furious pace of new investments in therapeutic tech platforms and biotech startups. And the top 100 players completely dominated the megabillions game.
Read more